Search
Search Results
##search.searchResults.foundPlural##
-
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
825PDF: 540HTML: 4026 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
650PDF: 249Html: 33 -
-
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2857PDF: 960HTML: 7344 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1859PDF: 722HTML: 2113Untitled: 222Untitled: 156Untitled: 176Untitled: 160Untitled: 168Untitled: 183Untitled: 189 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
891PDF: 490HTML: 141Suppl. Files: 327 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3401PDF: 1297HTML: 1908Fig.1: 203Fig. 2: 214 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1833PDF: 821HTML: 10240Figures 1,2,3: 185 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3343PDF: 585HTML: 668 -
LIVER IRON CONTENT IN INDIVIDUALS WITH LIVER IRON CONTENT IN INDIVIDUALS WITH Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS.: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS. Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA
104PDF: 39Suppl. Files: 7HTML: 0 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4536PDF: 1936HTML: 17801 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1063PDF: 691HTML: 79 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1557PDF: 789HTML: 205 -
-
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1376PDF: 842HTML: 10063cover letter to the editor: 167tile page: 249 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1496PDF: 1234HTML: 510 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2940PDF: 1597HTML: 237 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1859PDF: 802HTML: 3607 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1635PDF: 819HTML: 174 -
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1327PDF: 873HTML: 1034Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 179 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
733PDF: 466HTML: 6272 -
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
2931PDF: 1347HTML: 159 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3033PDF: 910HTML: 1997 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7646PDF: 2433HTML: 1739Table 1.: 212Table 2.: 221Table 3.: 205Table 4.: 205 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4073PDF: 1155HTML: 1951Fig.1: 219Fig. 2: 113Table 1: 204Table2: 222Table 3: 201 -
VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
2738PDF: 1087HTML: 2578 -
EXERCISE STRESS ECHOCARDIOGRAPHY WITH TISSUE DOPPLER IMAGING (TDI) DETECTS EARLY SYSTOLIC DYSFUNCTION IN BETA-THALASSEMIA MAJOR PATIENTS WITHOUT CARDIAC IRON OVERLOAD
1339PDF: 813HTML: 7869Manuscript after revision: 243Barbero10328-36310-after revision: 235 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1373PDF: 476HTML: 182







